Literature DB >> 25225948

Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.

Kondwani C Jambo1, Dominic H Banda, Louise Afran, Anstead M Kankwatira, Rose D Malamba, Theresa J Allain, Stephen B Gordon, Robert S Heyderman, David G Russell, Henry C Mwandumba.   

Abstract

RATIONALE: HIV-infected persons on antiretroviral therapy (ART) remain at higher risk of pulmonary tuberculosis (TB) than HIV-uninfected individuals. This increased susceptibility may be caused by impairment of alveolar macrophage (AM) function and/or mycobacteria-specific alveolar CD4(+) T-cell responses observed in HIV-infected ART-naive adults.
OBJECTIVES: To determine whether ART was associated with improvement in both AM function, assessed by phagosomal proteolysis, and alveolar CD4(+) T-cell responses to Mycobacterium in HIV-infected individuals.
METHODS: Peripheral blood was drawn and bronchoalveolar lavage (BAL) performed on healthy, 35 HIV-uninfected, 25 HIV-infected ART-naive, and 50 HIV-infected ART-treated asymptomatic adults. Phagosomal proteolysis of AM was assessed with fluorogenic beads. Mycobacteria-specific CD4(+) T-cell responses were measured by intracellular cytokine staining.
MEASUREMENTS AND MAIN RESULTS: HIV-infected adults on ART exhibited lower plasma HIV viral load and higher blood CD4(+) T-cell count than ART-naive adults. AM proteolysis and total mycobacteria-specific Th1 CD4(+) T-cell responses in individuals on ART for greater than or equal to 4 years were similar to HIV-uninfected control subjects but those on ART for less than 4 years had impaired responses. Total influenza-specific alveolar Th1 CD4(+) T-cell responses were intact in all individuals receiving ART. In contrast, BAL and blood mycobacteria-specific polyfunctional CD4(+) T-cell responses were impaired in adults on ART irrespective of duration.
CONCLUSIONS: AM and mycobacteria-specific alveolar CD4(+) T-cell responses in HIV-infected adults on ART for less than 4 years are impaired and may partly explain the high risk of TB in HIV-infected individuals on ART. Strategies to augment ART to improve lung immune cell function and reduce the high incidence of TB in HIV-infected adults who initiate ART should be investigated.

Entities:  

Keywords:  ART; HIV; Mycobacterium tuberculosis; T cells; macrophages

Mesh:

Substances:

Year:  2014        PMID: 25225948      PMCID: PMC4299580          DOI: 10.1164/rccm.201405-0864OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.

Authors:  Donatella Ciuffreda; Denis Comte; Matthias Cavassini; Emiliano Giostra; Leo Bühler; Monika Perruchoud; Markus H Heim; Manuel Battegay; Daniel Genné; Beat Mulhaupt; Raffaele Malinverni; Carl Oneta; Enos Bernasconi; Martine Monnat; Andreas Cerny; Christian Chuard; Jan Borovicka; Gilles Mentha; Manuel Pascual; Jean-Jacques Gonvers; Giuseppe Pantaleo; Valérie Dutoit
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

Review 2.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

3.  Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.

Authors:  Sunil Kannanganat; Bill G Kapogiannis; Chris Ibegbu; Lakshmi Chennareddi; Paul Goepfert; Harriet L Robinson; Jeffrey Lennox; Rama Rao Amara
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

4.  Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection.

Authors:  Kathleen M Neuzil; Christopher S Coffey; Ed F Mitchel; Marie R Griffin
Journal:  J Acquir Immune Defic Syndr       Date:  2003-11-01       Impact factor: 3.731

5.  HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

Authors:  Charlotte Lewden; Genevieve Chene; Philippe Morlat; Francois Raffi; Michel Dupon; Pierre Dellamonica; Jean-Luc Pellegrin; Christine Katlama; Francois Dabis; Catherine Leport
Journal:  J Acquir Immune Defic Syndr       Date:  2007-09-01       Impact factor: 3.731

6.  Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.

Authors:  Emily K Forbes; Clare Sander; Edward O Ronan; Helen McShane; Adrian V S Hill; Peter C L Beverley; Elma Z Tchilian
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

Authors:  Stephen B Gordon; Rose Malamba; Neema Mthunthama; Elizabeth R Jarman; Kondwani Jambo; Khuzwayo Jere; Eduard E Zijlstra; Malcolm E Molyneux; John Dennis; Neil French
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

8.  Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

Authors:  Martin W G Brinkhof; Andrew Boulle; Ralf Weigel; Eugène Messou; Colin Mathers; Catherine Orrell; François Dabis; Margaret Pascoe; Matthias Egger
Journal:  PLoS Med       Date:  2009-04-28       Impact factor: 11.069

9.  Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.

Authors:  Thomas J Scriba; Barbara Kalsdorf; Deborah-Ann Abrahams; Fatima Isaacs; Jessica Hofmeister; Gillian Black; Hisham Y Hassan; Robert J Wilkinson; Gerhard Walzl; Sebastian J Gelderbloem; Hassan Mahomed; Gregory D Hussey; Willem A Hanekom
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

10.  CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells.

Authors:  Kapilan Kugathasan; Elizabeth K Roediger; Cherrie-Lee Small; Sarah McCormick; Pingchang Yang; Zhou Xing
Journal:  BMC Immunol       Date:  2008-08-13       Impact factor: 3.615

View more
  19 in total

Review 1.  Update in Mycobacterium tuberculosis lung disease 2014.

Authors:  Paul Elkington; Alimuddin Zumla
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

2.  Dysregulation of Alveolar Macrophage PPARγ, NADPH Oxidases, and TGFβ1 in Otherwise Healthy HIV-Infected Individuals.

Authors:  Samantha M Yeligar; Janine M Ward; Frank L Harris; Lou Ann S Brown; David M Guidot; Sushma K Cribbs
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-24       Impact factor: 2.205

Review 3.  HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication.

Authors:  Jonathan Herskovitz; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-23       Impact factor: 4.147

4.  Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients.

Authors:  Leopoldo N Segal; Jose C Clemente; Yonghua Li; Chunhai Ruan; Jane Cao; Mauricio Danckers; Alison Morris; Sarah Tapyrik; Benjamin G Wu; Philip Diaz; Gregory Calligaro; Rodney Dawson; Richard N van Zyl-Smit; Keertan Dheda; William N Rom; Michael D Weiden
Journal:  Cell Host Microbe       Date:  2017-03-30       Impact factor: 21.023

Review 5.  Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa.

Authors:  Sara Sardashti; Mehrnoosh Samaei; Mona Mohammadi Firouzeh; Seyed Ali Mirshahvalad; Fatemeh Golsoorat Pahlaviani; SeyedAhmad SeyedAlinaghi
Journal:  World J Virol       Date:  2015-05-12

6.  Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.

Authors:  Catherine Riou; Ramla F Tanko; Andreia P Soares; Lindi Masson; Lise Werner; Nigel J Garrett; Natasha Samsunder; Quarraisha Abdool Karim; Salim S Abdool Karim; Wendy A Burgers
Journal:  J Immunol       Date:  2015-07-20       Impact factor: 5.422

7.  Th22 Cells Are a Major Contributor to the Mycobacterial CD4+ T Cell Response and Are Depleted During HIV Infection.

Authors:  Rubina Bunjun; Fidilia M A Omondi; Mohau S Makatsa; Roanne Keeton; Jerome M Wendoh; Tracey L Müller; Caryn S L Prentice; Robert J Wilkinson; Catherine Riou; Wendy A Burgers
Journal:  J Immunol       Date:  2021-08-13       Impact factor: 5.422

8.  Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas.

Authors:  Collin R Diedrich; Jennifer O'Hern; Maximiliano G Gutierrez; Nafiesa Allie; Patricia Papier; Graeme Meintjes; Anna K Coussens; Helen Wainwright; Robert J Wilkinson
Journal:  J Infect Dis       Date:  2016-07-26       Impact factor: 5.226

9.  Alveolar T-helper 17 responses to streptococcus pneumoniae are preserved in ART-untreated and treated HIV-infected Malawian adults.

Authors:  Chikondi Peno; Dominic H Banda; Ndaru Jambo; Anstead M Kankwatira; Rose D Malamba; Theresa J Allain; Daniela M Ferreira; Robert S Heyderman; David G Russell; Henry C Mwandumba; Kondwani C Jambo
Journal:  J Infect       Date:  2017-11-29       Impact factor: 6.072

10.  Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung.

Authors:  Davide Pisu; Lu Huang; Vipin Narang; Monique Theriault; Gabrielle Lê-Bury; Bernett Lee; Agnes E Lakudzala; David T Mzinza; David V Mhango; Steven C Mitini-Nkhoma; Kondwani C Jambo; Amit Singhal; Henry C Mwandumba; David G Russell
Journal:  J Exp Med       Date:  2021-07-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.